Understanding muscle loss in patients with inflammatory bowel disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prevalence of sarcopenia, a condition characterized by muscle loss, in patients suffering from severe flare-ups of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Participants will be divided into two cohorts: one receiving medical treatment and the other undergoing colectomy. Evaluations will include examinations, laboratory tests, and surveys conducted at the onset of the flare-up and again one year later to assess changes in nutritional status and microbiota composition. The study seeks to understand the impact of these conditions on muscle health and overall prognosis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All adult patients experiencing an acute flare-up of their bowel disease (ulcerative colitis or Crohn's disease) admitted to a hospital in the Region Västra Götaland and Stockholm are invited to participate in the study.

Exclusion Criteria:

* Not wishing to participate in the study Inability to understand the language or study procedures

Where it's running

• Sahlgrenska University Hospital
  Gothenburg, Sweden Recruiting

Study contacts

• Principal investigator: Jonas Varkey, MD. Ph D — Sahlgrenska University Hospital
• Study coordinator: Jonas Varkey, MD, PhD
• Email: jonas.varkey@vgregion.se
• Phone: 0046764030388

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How nutrition and body composition relate to outcomes in people with IBD

  This study will see if nutrition and muscle mass affect outcomes in people with Crohn's disease or ulcerative colitis who are starting advanced medicines or having IBD-related surgery.

  Recruiting Barts & The London NHS Trust · London · NCT06550310

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Bone marrow mesenchymal stem cell injection for sarcopenia

  This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.

  Recruiting Phase 1/2 GuangZhou Cellgenes Biotechnology Co., Ltd. · Guangzhou · NCT07865676

• GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes

  This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.

  Recruiting Istanbul Saglik Bilimleri University · Istanbul, Kucukcekmece · NCT07858864

• Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

  We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

  Recruiting Marmara University · Istanbul, Istanbul · NCT07855419

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.